Identification and functional evaluation of GRIA1 missense and truncation variants in individuals with ID: an emerging neurodevelopmental syndrome
Identification and functional evaluation of GRIA1 missense and truncation variants in individuals with ID: an emerging neurodevelopmental syndrome
GRIA1 encodes the GluA1 subunit of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptors, which are ligand-gated ion channels that act as excitatory receptors for the neurotransmitter L-glutamate (Glu). AMPA receptors (AMPARs) are homo- or heteromeric protein complexes with four subunits, each encoded by different genes, GRIA1 to GRIA4. Although GluA1-containing AMPARs have a crucial role in brain function, the human phenotype associated with deleterious GRIA1 sequence variants has not been established. Subjects with de novo missense and nonsense GRIA1 variants were identified through international collaboration. Detailed phenotypic and genetic assessments of the subjects were carried out and the pathogenicity of the variants was evaluated in vitro to characterize changes in AMPAR function and expression. In addition, two Xenopus gria1 CRISPR-Cas9 F0 models were established to characterize the in vivo consequences. Seven unrelated individuals with rare GRIA1 variants were identified. One individual carried a homozygous nonsense variant (p.Arg377Ter), and six had heterozygous missense variations (p.Arg345Gln, p.Ala636Thr, p.Ile627Thr, and p.Gly745Asp), of which the p.Ala636Thr variant was recurrent in three individuals. The cohort revealed subjects to have a recurrent neurodevelopmental disorder mostly affecting cognition and speech. Functional evaluation of major GluA1-containing AMPAR subtypes carrying the GRIA1 variant mutations showed that three of the four missense variants profoundly perturb receptor function. The homozygous stop-gain variant completely destroys the expression of GluA1-containing AMPARs. The Xenopus gria1 models show transient motor deficits, an intermittent seizure phenotype, and a significant impairment to working memory in mutants. These data support a developmental disorder caused by both heterozygous and homozygous variants in GRIA1 affecting AMPAR function.
AMPA receptor, CRISPR, glutamate receptor 1, GRIA1, iGluR, neurodevelopmental impairment, Xenopus, free movement pattern Y maze
1217-1241
Ismail, Vardha
e10a39c7-34e9-482b-975f-514c7b4309b4
Zachariassen, Linda G.
9ef418ac-648b-4689-8399-39cd4a42bdba
Godwin, Annie
90ba88ea-4a7c-44f4-bf70-9015c0d33194
Sahakian, Mane
8fddfc1a-feb8-4f93-89f3-14206a841fe0
Ellard, Sian
6c9b0ede-8980-4602-b063-444b165baa09
Stals, Karen L.
145b7d51-cea5-485d-9f83-614ca062efb6
Baple, Emma
3c26ed20-f1d8-465c-9c20-badd025bb731
Brown, Kate Tatton
03f0600b-2a9d-47b2-b495-d6c04f2157ab
Foulds, Nicola
5e153e9f-caae-45f5-b6f0-943bd567558e
Wheway, Gabrielle
2e547e5d-b921-4243-a071-2208fd4cc090
Parker, Matthew O.
c0074db2-b82c-47ba-a9b9-e42f278eeeb3
Lyngby, Signe M.
131736ce-4b9c-4035-bf47-f95a0c2efd96
Pedersen, Miriam G.
d11b517b-e902-4aa0-87ca-3f8db3a1531e
Desir, Julie
8844e390-7354-4149-908e-f1e07790e9ec
Bayat, Allan
cfb50f98-bac3-450f-9daf-affa38112705
Musgaard, Maria
86d2e010-686d-4814-8f0d-21f88c4cbcfd
Guille, Matthew
dfefb828-7c5b-4529-8df6-d7a10d8d5b67
Kristensen, Anders S.
a04ef18d-97a8-417c-93d2-9fe8f0862311
Baralle, Diana
faac16e5-7928-4801-9811-8b3a9ea4bb91
7 July 2022
Ismail, Vardha
e10a39c7-34e9-482b-975f-514c7b4309b4
Zachariassen, Linda G.
9ef418ac-648b-4689-8399-39cd4a42bdba
Godwin, Annie
90ba88ea-4a7c-44f4-bf70-9015c0d33194
Sahakian, Mane
8fddfc1a-feb8-4f93-89f3-14206a841fe0
Ellard, Sian
6c9b0ede-8980-4602-b063-444b165baa09
Stals, Karen L.
145b7d51-cea5-485d-9f83-614ca062efb6
Baple, Emma
3c26ed20-f1d8-465c-9c20-badd025bb731
Brown, Kate Tatton
03f0600b-2a9d-47b2-b495-d6c04f2157ab
Foulds, Nicola
5e153e9f-caae-45f5-b6f0-943bd567558e
Wheway, Gabrielle
2e547e5d-b921-4243-a071-2208fd4cc090
Parker, Matthew O.
c0074db2-b82c-47ba-a9b9-e42f278eeeb3
Lyngby, Signe M.
131736ce-4b9c-4035-bf47-f95a0c2efd96
Pedersen, Miriam G.
d11b517b-e902-4aa0-87ca-3f8db3a1531e
Desir, Julie
8844e390-7354-4149-908e-f1e07790e9ec
Bayat, Allan
cfb50f98-bac3-450f-9daf-affa38112705
Musgaard, Maria
86d2e010-686d-4814-8f0d-21f88c4cbcfd
Guille, Matthew
dfefb828-7c5b-4529-8df6-d7a10d8d5b67
Kristensen, Anders S.
a04ef18d-97a8-417c-93d2-9fe8f0862311
Baralle, Diana
faac16e5-7928-4801-9811-8b3a9ea4bb91
Ismail, Vardha, Zachariassen, Linda G., Godwin, Annie, Sahakian, Mane, Ellard, Sian, Stals, Karen L., Baple, Emma, Brown, Kate Tatton, Foulds, Nicola, Wheway, Gabrielle, Parker, Matthew O., Lyngby, Signe M., Pedersen, Miriam G., Desir, Julie, Bayat, Allan, Musgaard, Maria, Guille, Matthew, Kristensen, Anders S. and Baralle, Diana
(2022)
Identification and functional evaluation of GRIA1 missense and truncation variants in individuals with ID: an emerging neurodevelopmental syndrome.
American Journal of Human Genetics, 109 (7), .
(doi:10.1016/j.ajhg.2022.05.009).
Abstract
GRIA1 encodes the GluA1 subunit of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptors, which are ligand-gated ion channels that act as excitatory receptors for the neurotransmitter L-glutamate (Glu). AMPA receptors (AMPARs) are homo- or heteromeric protein complexes with four subunits, each encoded by different genes, GRIA1 to GRIA4. Although GluA1-containing AMPARs have a crucial role in brain function, the human phenotype associated with deleterious GRIA1 sequence variants has not been established. Subjects with de novo missense and nonsense GRIA1 variants were identified through international collaboration. Detailed phenotypic and genetic assessments of the subjects were carried out and the pathogenicity of the variants was evaluated in vitro to characterize changes in AMPAR function and expression. In addition, two Xenopus gria1 CRISPR-Cas9 F0 models were established to characterize the in vivo consequences. Seven unrelated individuals with rare GRIA1 variants were identified. One individual carried a homozygous nonsense variant (p.Arg377Ter), and six had heterozygous missense variations (p.Arg345Gln, p.Ala636Thr, p.Ile627Thr, and p.Gly745Asp), of which the p.Ala636Thr variant was recurrent in three individuals. The cohort revealed subjects to have a recurrent neurodevelopmental disorder mostly affecting cognition and speech. Functional evaluation of major GluA1-containing AMPAR subtypes carrying the GRIA1 variant mutations showed that three of the four missense variants profoundly perturb receptor function. The homozygous stop-gain variant completely destroys the expression of GluA1-containing AMPARs. The Xenopus gria1 models show transient motor deficits, an intermittent seizure phenotype, and a significant impairment to working memory in mutants. These data support a developmental disorder caused by both heterozygous and homozygous variants in GRIA1 affecting AMPAR function.
Text
1-s2.0-S0002929722002154-main
- Version of Record
More information
Accepted/In Press date: 11 May 2022
e-pub ahead of print date: 7 June 2022
Published date: 7 July 2022
Keywords:
AMPA receptor, CRISPR, glutamate receptor 1, GRIA1, iGluR, neurodevelopmental impairment, Xenopus, free movement pattern Y maze
Identifiers
Local EPrints ID: 494114
URI: http://eprints.soton.ac.uk/id/eprint/494114
ISSN: 0002-9297
PURE UUID: 462d1db5-3fa3-4272-850c-7ef696f91183
Catalogue record
Date deposited: 24 Sep 2024 16:39
Last modified: 25 Sep 2024 01:55
Export record
Altmetrics
Contributors
Author:
Vardha Ismail
Author:
Linda G. Zachariassen
Author:
Annie Godwin
Author:
Mane Sahakian
Author:
Sian Ellard
Author:
Karen L. Stals
Author:
Emma Baple
Author:
Kate Tatton Brown
Author:
Nicola Foulds
Author:
Matthew O. Parker
Author:
Signe M. Lyngby
Author:
Miriam G. Pedersen
Author:
Julie Desir
Author:
Allan Bayat
Author:
Maria Musgaard
Author:
Matthew Guille
Author:
Anders S. Kristensen
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics